Table 1 Clinical characteristics.
|  | Normal (n = 79) | Motor developmental delay (n = 11) | p-value |
|---|---|---|---|
Infantile characteristics | |||
Sex (female) | 26 (32.9) | 8 (72.7) | 0.018* |
Gestational age (weeks:days) | 29:0 (2:6) | 27:3 (2:3) | 0.077 |
Postnatal age (weeks:days) at video recordings | 11:0 (3:0) | 12:3 (2:3) | 0.151 |
Birth weight (g) | 1149.2 (361.3) | 1029.3 (383.0) | 0.308 |
Global score of HINE | 66.2 (7.7) | 57.5 (10.1) | 0.001* |
Categories of GMA |  |  |  < 0.001* |
  Poor repertoire | 17 (21.5) | 5 (45.5) |  |
  Cramped synchronized | 0 (0.0) | 2 (18.2) |  |
  Chaotic | 1 (1.3) | 2 (18.2) |  |
Neonatal morbidities | |||
1-Min Apgar score†| 4.7 (2.0) | 3.0 (1.9) | 0.008* |
5-Min Apgar score†| 7.2 (1.8) | 5.1 (1.8) | 0.002* |
Bronchopulmonary dysplasia (moderate to severe) | 22 (27.8) | 6 (54.5) | 0.073 |
Antenatal steroid†| 53 (67.9) | 4 (36.4) | 0.051 |
Periventricular leukomalacia | 5 (6.3) | 5 (45.5) |  < 0.001* |
Intraventricular hemorrhage (grade III–IV) | 3 (3.8) | 4 (36.4) | 0.004* |
Invasive ventilator use (days) | 10.1 (15.9) | 38.2 (31.2) | 0.014* |
Patent ductus arteriosus | 42 (53.2) | 10 (90.9) | 0.022* |
Treatments of patent ductus arteriosus | Â | Â | 0.585 |
  Pharmacological closure | 11 (13.9) | 3 (27.3) |  |
  Surgical closure | 11 (13.9) | 1 (9.1) |  |
 Retinopathy of prematurity (stage 3–5) | 5 (6.3) | 3 (27.3) | 0.055 |
 Sepsis | 10 (12.7) | 5 (45.5) | 0.006* |
 Seizure | 1 (1.3) | 4 (36.4) | 0.001* |
Maternal characteristics | |||
Maternal preeclampsia | 12 (15.2) | 0 (0.0) | 0.348 |
Gestational diabetes mellitus | 10 (12.7) | 0 (0.0) | 0.604 |
Multiple gestations | 46 (58.2) | 7 (63.6) | 1.000 |
Maternal chorioamnionitis | 23 (29.1) | 2 (18.2) | 0.721 |
